Radiofrequency Combined with Intratumoral Immunotherapy: Preclinical Results and Safety in Metastatic Colorectal Carcinoma.

MLA

Seguin, Johanne, et al. “Radiofrequency Combined with Intratumoral Immunotherapy: Preclinical Results and Safety in Metastatic Colorectal Carcinoma.” Pharmaceutics, vol. 16, no. 3, Mar. 2024, p. 315. EBSCOhost, https://doi.org/10.3390/pharmaceutics16030315.

APA

Seguin, J., El Hajjam, M., Legagneux, J., Diakhaby, S., Mignet, N., Boudy, V., Toussaint, B., Peschaud, F., Emile, J. F., Capron, C., & Malafosse, R. (2024). Radiofrequency Combined with Intratumoral Immunotherapy: Preclinical Results and Safety in Metastatic Colorectal Carcinoma. Pharmaceutics, 16(3), 315. https://doi.org/10.3390/pharmaceutics16030315

Chicago

Seguin, Johanne, Mostafa El Hajjam, Josette Legagneux, Sarah Diakhaby, Nathalie Mignet, Vincent Boudy, Balthazar Toussaint, et al. 2024. “Radiofrequency Combined with Intratumoral Immunotherapy: Preclinical Results and Safety in Metastatic Colorectal Carcinoma.” Pharmaceutics 16 (3): 315. doi:10.3390/pharmaceutics16030315.